1,363 results on '"Lesiak, Maciej"'
Search Results
102. The bioresorbable magnesium scaffold (Magmaris)—State of the art: From basic concept to clinical application
103. Preeclampsia and Fetal Growth Restriction as Risk Factors of Future Maternal Cardiovascular Disease—A Review
104. Disastrous effects of anabolic steroids abuse: a peculiar case of heart failure and toxic hepatitis in a young bodybuilder
105. Lightning 12: A new player in the field of pulmonary percutaneous mechanical thrombectomy
106. Neopterin as a predictive biomarker of postoperative atrial fibrillation following coronary artery bypass grafting
107. Simultaneous use of implantable cardioverter-defibrillator in a patient with a preexisting deep brain stimulator: A proposed protocol of implantation to avoid dangerous interactions
108. TCT-149 Does the Involvement of Left Circumflex Coronary Artery Ostium Affect Prognosis in Patients Undergoing Percutaneous Coronary Intervention for Left Main Disease?
109. Stand-Alone Left Atrial appendage occlusion for throMboembolism prevention in nonvalvular Atrial fibrillatioN DiseasE Registry (SALAMANDER): protocol for a prospective observational nationwide study
110. TCT-188 Safety and Efficacy of Intravascular Lithotripsy in the Management of Stent Underexpansion Among Elderly Patients
111. Coronary Artery Ectasia Database -- Poland (CARED-POL). The rationale and design of the multicenter nationwide registry.
112. Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST‐EU Registry
113. Bioresorbable Vascular Scaffold
114. Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds -- magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort.
115. The influence of severe mitral regurgitation on major adverse cardiac and cerebrovascular events after myocardial infarction in 1-year follow-up: Data from the PL-ACS registry.
116. Pulmonary artery systolic pressure at 1-month predicts 1-year survival after transcatheter aortic valve implantation
117. Follow-up and characteristics of recipients of cardiac resynchronization therapy with and without a defibrillator
118. Longer Hospitalizations and Higher In-Hospital Mortality for Acute Heart Failure during the COVID-19 Pandemic in Larger vs. Smaller Cardiology Departments: Subanalysis of the COV-HF-SIRIO 6 Multicenter Study
119. Acute-on-chronic pulmonary embolism-induced right ventricular failure salvaged by combined catheter-directed therapy and levosimendan infusion
120. Intravascular Lithotripsy as a Novel Treatment Method for Calcified Unprotected Left Main Diseases—Comparison to Rotational Atherectomy—Short-Term Outcomes
121. Changes in Cell Biology under the Influence of Low-Level Laser Therapy
122. Recall devices: Defects at initial visit and during remote monitoring supported follow‐up
123. Increased endocan expression as a biomarker of endothelial dysfunction in patients with metabolic syndrome
124. Pre-hospital treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams. Expert position update 2022
125. Peripartum cardiomyopathy — challenges of diagnosis and management. Stay alert and implement BOARD treatment
126. Bland-White-Garland syndrome in a 35-year-old professional soldier: a case report
127. Dual antiplatelet therapy for reduction in mortality in patients with acute and chronic coronary syndromes
128. Retrograde Chronic Total Occlusion Percutaneous Coronary Interventions:Predictors of Procedural Success From the ERCTO Registry
129. Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome : Rationale and design of the ELECTRA-SIRIO 2 trial
130. Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease:Final results of the SYNTAX II study
131. Segmental comparison between a dedicated bifurcation stent and balloon angioplasty using intravascular ultrasound and three‐dimensional quantitative coronary angiography: A subgroup analysis of the Tryton IDE randomized trial
132. Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry
133. “Orbital-Tripsy” — Orbital atherectomy facilitated by Shockwave Intravascular Lithotripsy: Novel bailout strategy of percutaneous coronary intervention in heavily calcified coronary lesions.
134. Twelve-month results of a Paclitaxel Releasing Balloon in Patients Presenting with In-stent Restenosis First-in-Man (PEPPER) trial
135. Impact of Atrial Remodeling on Heart Rhythm After Radiofrequency Ablation and Mitral Valve Operations
136. Endovascular closure of coronary artery to pulmonary artery fistula with giant aneurysm
137. Outcomes of the two generations of bioresorbable scaffolds (Magmaris vs. Absorb) in acute coronary syndrome in routine clinical practice
138. Prognostic Value of Pulmonary Artery Pulsatility Index in Right Ventricle Failure-Related Mortality in Inoperable Chronic Thromboembolic Pulmonary Hypertension
139. Neutrophil-to-lymphocyte ratio as a predictor of inflammatory response in patients with acute kidney injury after transcatheter aortic valve implantation
140. Management and predictors of clinical events in 75 686 patients with acute myocardial infarction
141. Percutaneous Coronary Intervention vs. Coronary Artery Bypass Grafting for Treating In-Stent Restenosis in Unprotected-Left Main: LM-DRAGON-Registry
142. Chronic thromboembolic pulmonary hypertension complicated by left main compression syndrome
143. Circulating microRNAs in patients with aneurysmal dilatation of coronary arteries
144. Serum matrix metalloproteinase-8 level in patients with coronary artery abnormal dilatation
145. The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot Experience
146. Retrograde Chronic Total Occlusion Percutaneous Coronary Interventions
147. Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial
148. TCTAP A-036 Annual Operator Volume Among Patients Treated Using Percutaneous Coronary Interventions With Rotational Atherectomy and Procedural Outcomes - Analysis Based on a Large National Registry
149. TCTAP A-054 Shockwave Intravascular Lithotripsy as a Novel Strategy for the Treatment of Stent Underexpansion Caused by Calcified Plaques
150. Very long-term follow-up of patients with coronary bifurcation lesions treated with bioresorbable scaffolds
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.